BioSpace News Archive

Press Releases

Humacyte Board of Directors Strengthened with Addition of John P. Bamforth and Keith Anthony Jones

July 16, 2024
·
7 min read
Press Releases

SFA Therapeutics Strengthens Management Team with Appointment of Chief Operating Officer

July 16, 2024
·
4 min read
Press Releases

Sionna Therapeutics Expands Pipeline with Multiple Clinical Stage Cystic Fibrosis Compounds Through a License Agreement with AbbVie

July 16, 2024
·
5 min read
Press Releases

Epilepsy Foundation Further Strengthens Network Relationships & National Partnerships with New Chief Engagement Officer

July 16, 2024
·
4 min read
Press Releases

Metabolon Expands Library to Include 70 Pesticides, Advancing Human Exposome Insights through Metabolomics

July 16, 2024
·
3 min read
Press Releases

Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada

July 16, 2024
·
5 min read
Press Releases

argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

July 16, 2024
·
9 min read
Press Releases

CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

July 16, 2024
·
5 min read
Press Releases

Main Life received Targretin® (Bexarotene) Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma

July 16, 2024
·
2 min read
Press Releases

Biosyngen’s BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

July 16, 2024
·
6 min read